glutamine has been researched along with Parkinsonian Disorders in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diaz, J; Guilloux, JP; Massart, R; Mignon, V; Sokoloff, P | 1 |
| Bielicki, G; Chassain, C; Donnat, JP; Durif, F; Eschalier, A; Renou, JP | 1 |
| Kanamatsu, T; Nambu, A; Okamoto, K; Otsuki, T; Takada, M; Tokuno, H; Tsukada, Y; Umeda, M; Watanabe, H | 1 |
| Bielicki, G; Chassain, C; Durand, E; Durif, F; Essafi, F; Lolignier, S; Traoré, A | 1 |
| Bédard, PJ; Blanchet, PJ; Calon, F; Di Paolo, T; Ghribi, O; Goulet, M; Grondin, R; Morissette, M | 1 |
5 other study(ies) available for glutamine and Parkinsonian Disorders
| Article | Year |
|---|---|
Striatal GPR88 expression is confined to the whole projection neuron population and is regulated by dopaminergic and glutamatergic afferents.
Topics: Animals; Corpus Striatum; Dendrites; Dopamine; Dopamine Agents; Fluorescent Antibody Technique; Glutamine; Haplorhini; Immunohistochemistry; In Situ Hybridization; Levodopa; Male; Microscopy, Electron, Transmission; Neurons, Afferent; Parkinsonian Disorders; Rats; Rats, Wistar; Receptors, G-Protein-Coupled | 2009 |
Cerebral glutamate metabolism in Parkinson's disease: an in vivo dynamic (13)C NMS study in the rat.
Topics: Animals; Antiparkinson Agents; Basal Ganglia; Carbon Isotopes; Disease Models, Animal; Dopamine; Glutamic Acid; Glutaminase; Glutamine; Infusions, Intravenous; Levodopa; Lipid Metabolism; Magnetic Resonance Spectroscopy; Male; Neostriatum; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Sodium Acetate | 2005 |
Changes in the rates of the tricarboxylic acid (TCA) cycle and glutamine synthesis in the monkey brain with hemiparkinsonism induced by intracarotid infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): studies by non-invasive 13C-magnetic reso
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Basal Ganglia; Brain; Carbon Isotopes; Citric Acid Cycle; Disease Models, Animal; Dopamine; Female; Glutamine; Macaca fascicularis; Magnetic Resonance Spectroscopy; Parkinsonian Disorders | 2007 |
Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson's disease, the MPTP-intoxicated mouse.
Topics: Animals; Cerebral Cortex; Corpus Striatum; Disease Models, Animal; Dopamine; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; In Vitro Techniques; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Inbred C57BL; Neural Pathways; Neurochemistry; Neurotransmitter Agents; Parkinsonian Disorders; Protons; Substantia Nigra; Synaptic Transmission; Up-Regulation | 2008 |
Alteration of glutamate receptors in the striatum of dyskinetic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Benzazepines; Corpus Striatum; Dopamine Agonists; Female; Glutamic Acid; Glutamine; Glycine; Macaca fascicularis; Ovariectomy; Parkinsonian Disorders; Receptors, Glutamate; Reference Values | 2002 |